NSW Pharmaceutical Science Group

The NSW Pharmaceutical Science Group was established in 1959 to “promote the dissemination and exchange of scientific and technical knowledge, particularly related to the Pharmaceutical Sciences”.

The Group has pursued this objective by the regular organisation of seminars with a panel of expert presenters. The presentations address specific topics or themes as variously applying to production, quality assurance, laboratory, regulatory and R&D of therapeutic goods.

 

Upcoming Events

 Watch this space! 

 

Past Events

Expand to view available recordings and presentations

Expand AllCollapse All

Vaccine Technologies Update - Wednesday 14 June 2023 Towards distributed manufacture of nanomedicines: Dr Dai Hayward, CEO Micropore Technologies (UK) Recent developments in RNA R&D and manufacturing in NSW: Prof Pall Thordarson, Director, RNA Institute UNSW Click here to see the seminar recording

Schedule

Committee

Position
Data pager
Data pager
12
Page size:
 25 items in 2 pages
Show all 25
Chair - Mr Scott Colbourne
Chair - Mr Scott Colbourne
Secretary - Mr Scott Colbourne
Secretary - Mr Scott Colbourne
Treasurer - Mr David Edmonds
Treasurer - Mrs Noor Salman
Committee Member - Mrs Niesha Davis
Committee Member - Ms Ivon Diaz
Committee Member - Ms Ivon Diaz
Committee Member - Mr David Edmonds
Committee Member - Dr Sviatoslav Eliseenko
Committee Member - Ms Annette Fordham
Committee Member - Ms Annette Fordham
Committee Member - Dr William Glover
Committee Member - Dr WILLIAM GLOVER
Committee Member - Dr Chen Lim
Committee Member - Dr Jurgen Lindner
Committee Member - Dr Jurgen Lindner
Committee Member - Mr Denis Moore
Committee Member - Mrs Noor Salman Qamar

Become Connected

 

If you would like get connected with NSW Pharm Group please contact us

 

  Contact us

 

Article: Regulatory and Other Requirements in Drug Development

  

David Edmonds, December 2019.

 

This article describes how, in conjunction with good and comprehensive science, a knowledge of TGA/Regulatory requirements and guidelines at the earliest stages of drug discovery and development should enhance the quality of the drug development.

 

The article can be downloaded here.